1312 — Kontafarma China Holdings Share News
0.000.00%
Last trade - 00:00- HK$150.89m
- HK$181.12m
- HK$914.71m
Brief: Kontafarma China Notified That Shenzhen Stock Exchange Issued A Notice Of Criticism
Brief: Kontafarma China Sees Consol Net Profit For Six Months HK$17.1 Mln To HK$25.7 Mln
Brief: Kontafarma China Notified That Huakong Seg Received Advance Notice Of Administrative Penalties
Brief: Kontafarma China Says Shenzhen Stock Exchange Issued Notice Of Criticism Against Shenzhen Huakong Seg
Brief: Kontafarma China Says Ping An Tsumura To Buy 66% Stake In Shaanxi Unisplendour Life Care Pharmaceutical
Brief: Kontafarma China Sees Consol Net Loss Loss In Range Of HK$43.2 Mln To HK$64.8 Mln For FY
Brief: Tongfang Kontafarma Sees Net Loss For HY Of Approximately HK$28.4 Mln To HK$42.7 Mln
Brief: Tongfang Kontafarma Says Chai Hongjie Ceased To Act As Chairman
Brief: Tongfang Kontafarma's Unit To Sell 55.43% Stake In SPF (Beijing) Biotechnology At RMB159.7 Mln
Brief: Tongfang Kontafarma Says Unit To Sell 79.83% Of Apros Therapeutics
Brief: Tongfang Kontafarma Appoints Bai Pingyan As Executive Director
Brief: Tongfang Kontafarma Sees Loss Before Taxation For Six Months Of About HK$64.0 Mln To HK$89.0 Mln
Brief: Tongfang Kontafarma Says Unit To Engage Shanxi Industrial As General Contractor
Brief: Tongfang Kontafarma Updates On Transaction In Relation To Construction Contracts
Brief: Tongfang Kontafarma Says Unit Received Court Summons In Relation To Claim Made By Shanghai Haixin Pharmaceutical Co
Brief: Tongfang Kontafarma Sees FY Consolidated Net Loss
Brief: Tongfang Kontafarma Says Unit To Buy Land Use Rights Of Land In Baoji, Shaanxi
Brief: Tongfang Kontafarma Says Chai Hongjie Appointed As Chairman
Brief: Tongfang Kontafarma Holdings Sees Consol HY PBT Of HK$22.0 MLN To HK$32.0 MLN